Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis

OBJECTIVE: The neutrophil-to-lymphocyte ratio (NLR) is recognised as a suitable prognostic biomarker in patients with breast cancer. Nevertheless, the efficacy of this biomarker in predicting the pathological complete response (pCR) and survival in patients with breast cancer receiving neoadjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiong, Dong, Jie, Sun, Qingqing, Lu, Nannan, Pan, Yueyin, Han, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475153/
https://www.ncbi.nlm.nih.gov/pubmed/34561257
http://dx.doi.org/10.1136/bmjopen-2020-047957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475153/
https://www.ncbi.nlm.nih.gov/pubmed/34561257
http://dx.doi.org/10.1136/bmjopen-2020-047957

Ejemplares similares